• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DYAX:US

14.1300 USD 0.3000 2.17%

As of 17:10:00 ET on 12/24/2014.

Snapshot for Dyax Corp (DYAX)

Open: 13.8400 Day's Range: 13.8400 - 14.5300 Volume: 410,397
Previous Close: 13.8300 52wk Range: 6.0500 - 15.7000 1-Yr Rtn: +83.98%

Stock Chart for DYAX

No chart data available.
  • DYAX:US 14.1300
  • 1D
  • 1M
  • 1Y
13.8300
Interactive DYAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DYAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1000
Est. EPS (USD) (12/2014) -0.1100
Est. PEG Ratio -
Market Cap (M USD) 1,927.52
Shares Outstanding (M) 136.41
30 Day Average Volume 1,179,374
Price/Book (mrq) 18.3339
Price/Sale (ttm) 25.2415
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DYAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DYAX

Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.

Gustav A ChristensenPresident/CEOGeorge V MigauskyExec VP/CFO
Burt A AdelmanExec VP/Chief Medical OfcrAndrew AsheExec VP/General Counsel
More Company Profile & Key Executives for DYAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil